Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synnat Pharmaceuticals is an Indian pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The company maintains a strong focus on antiretroviral therapies, producing key components for HIV treatment such as Tenofovir and Emtricitabine. Operating out of state-of-the-art facilities in Visakhapatnam, Synnat provides custom synthesis and contract manufacturing services to global pharmaceutical partners. Their portfolio also extends into therapeutic areas including cardiovascular health, diabetes, and central nervous system disorders. The company is recognized for its commitment to quality standards and regulatory compliance in the global API market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synnat Pharmaceuticals.